Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Assembly Biosciences Inc Is A Clinical-Stage Biotechnology Company. The Company'S Pipeline Includes Multiple Clinical-Stage Investigational Therapies, Including: (1) Two Long-Acting Helicase-Primase Inhibitors (Hpi) For The Treatment Of Recurrent Genital Herpes; (2) An Orally Bioavailable Hepatitis Delta Virus Entry Inhibitor; And (3) A Potent Next-Generation Capsid Assembly Modulator Designed To Disrupt The Replication Cycle Of Hepatitis B Virus (Hbv) At Several Key Points. The Company'S Pipeline Also Includes A Novel, Oral Broad-Spectrum Non-Nucleoside Polymerase Inhibitor (Nnpi) For The Treatment Of Transplant-Related Herpesviruses.